The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 4 rounds in the feed, most often at Series C.
Investment firmelevagemedical.comRounds from 2023-11-09 to 2026-09-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Elucid Bioimaging Inc. A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series D Verified against 4 of 7 sources | $55M | 2026-09-02 | [ PART ] |
Imperative Care Medical devices and technologies for treating strokes and vascular diseases. | Convertible |
| $100M |
| 2026-03-19 |
| [ LEAD ] |
Galvanize Therapeutics Galvanize Therapeutics designs pulsed electric field energy devices for surgical ablation of soft tissue, targeting healthcare providers and hospitals. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2025-09-03 | [ PART ] |
Elucid Bioimaging Inc. A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $80M | 2023-11-09 | [ LEAD ] |